the aid library

LIST OPTIONS

Filter

9864

Sort by:

Direction:

Download (1894)

View PDF (1772)

Cancer
recommended

Hellen Gelband,Jha Prabhat, Rengaswamy Sankaranarayanan et al. The World Bank (2015) C1

This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte... more

Download (787)

View PDF (1410)

Guidance on temporary malaria control measures in Ebola-affected countries

World Health Organization (2014)

Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe... more

Download (497)

View PDF (2075)

Comprehensive cervical cancer control: A guide to essential practice
recommended

August Burns, Linda O’Neal Eckert, Susan Hariri et al (2014) C_WHO

This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition... more

Download (172)

View PDF (348)

WHO AFRO Outbreaks and Other Emergencies, Week 12: 18 - 24 March 2019; Data as reported by 17:00; 24 March 2019

World Health Organization WHO (2019) C_WHO

Cyclone in Mozambique and Zimbabwe Ebola virus disease in Democratic Republic of the Congo Humanitarian crisis in Mali Humanitarian crisis in Central African Republic.

Download (344)

View PDF (575)

GLI Guide to TB Specimen Referral Systems and Integrated Networks

Global Laboratory Initiative (GLI), Stop TB Partnership (2018) C1

This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though TB-focused in name, it offers integration-oriented assessment,... more

Download (479)

View PDF (516)

Alternative drinking-water disinfectants: Bromine, iodine and silver

World Health Organization (WHO) (2018) CC

Disinfection of drinking-water supplies has been one of the most significant public health advancements of the last century with respect to reducing waterborne disease.
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a numbe... more

Download (1100)

View PDF (1685)

Ebola Needs Analysis Project (ENAP): Sierra Leone Multi-Sector Assessment Reports (April 2015)

Assessment Capacities Project (2015)

The number of new Ebola infections in Sierra Leone is declining, despite the outbreak continuing to claim lives. New cases have dropped to around 9-12 per week, according to recent WHO figures. There were over 500 cases per week at the height of the crisis around late November 2014. The impact on t... more

Download (70)

View PDF (107)

Europe at a Crossroads - Dos and don’ts for authorities when responding to the Covid-19 pandemic

OCHA; Reliefweb; Amnesty International (2020) C2

Human rights must be at the centre of all prevention, preparedness, containment and treatment efforts from the start, in order to best protect public health and support the groups and people who are most at risk. States have an obligation to protect and guarantee everyone the right to the highest at... more

Download (88)

View PDF (115)

Q&A: Older people and COVID-19

World Health Organization WHO (2020) CC

Older people, and people of all ages with pre-existing medical conditions (such as diabetes, high blood pressure, heart disease, lung disease, or cancer) appear to develop serious illness more often than others. Here's how you can protect yourself.

Download (144)

View PDF (206)

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended

World Health Organization WHO (2020) C_WHO

Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ... more

Download (117)

View PDF (196)

What people living with HIV need to know about HIV and COVID-19

UNAIDS (2020) CC

COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung prob... more

Download (118)

View PDF (150)

Abdominal tuberculosis in Ecuador, a problem that is still not solved

Rojas, C. L., Polanco E. C., Vivar M. C. et al. (2020) CC

Journal of Clinical TB and other Mycobacterial Diseases uberculosis (TB) in the gastrointestinal tract or peritoneum is an uncommon condition in clinical practice. Its rarity, combined with its nonspecific presentations, makes this kind of extrapulmonary tuberculosis difficult to diagnose as it can... more

Download (130)

View PDF (173)

Эпидемиологический надзор за COVID-19: временные рекомендации, 14 февраля 2022 г.
recommended

World Health Organization WHO (2022) C_WHO

This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). New elements include: update of contact definitions, in line with latest cont... more

Download (78)

View PDF (145)

Guia de Vigilância Epidemiológica Covid-19: Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2019 - Atualizado em 20/01/2022

Ministerio da Saude, Brasilia (2022) CC

Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4

Download (140)

View PDF (173)

Managing epidemics: key facts about major deadly diseases

World Health Organization (WHO) (2018) C_WHO

Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered ... more

Download (111)

View PDF (169)

WHO Emergency Appeal: Health Crisis in Flood-Affected Pakistan
recommended

World Health Organization WHO (2022) C_WHO

Pakistan is on the verge of a public health disaster as a result of the massive monsoon rainfalls and unprecedented levels of flooding that are affecting 33 million people across the country. The risk of disease outbreaks is extremely high and malnutrition rates are rising. WHO requires US$ 81.5 m... more

Download (95)

View PDF (308)

New hope for leishmaniasis

Drugs for Neglected Diseases initiative DNDi (2022) CC

Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania p... more

Download (247)

View PDF (332)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (18)

View PDF (14)

Communicable and non-communicable diseases in Africa in 2021/22

World Health Organization Africa Region; WHO Africa World Health Organization Africa Region; WHO Africa (2023) C_WHO

This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra... more

Download (30)

View PDF (86)

Asthma management in low and middle income countries: case for change

Mortimer, K.; Reddel, H. K.; Pitrez, P. M.; et al. (2022) CC2

Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ... more

Cancer recommended

Comprehensive cervical cancer control: A guide to essential practice recommended

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV recommended

Эпидемиологический надзор за COVID-19: временные рекомендации, 14 февраля 2022 г. recommended

WHO Emergency Appeal: Health Crisis in Flood-Affected Pakistan recommended

Cancer
recommended

Comprehensive cervical cancer control: A guide to essential practice
recommended

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended

Эпидемиологический надзор за COVID-19: временные рекомендации, 14 февраля 2022 г.
recommended

WHO Emergency Appeal: Health Crisis in Flood-Affected Pakistan
recommended